About KiSS-1 receptor
KiSS-1 receptor (KISS1R) is a protein
from Homo sapiens identified by UniProt accession
Q969F8, 398 residues long.
MolForge cross-references it against 0 known binders and
474 disease associations.
Target properties
| Protein name | KiSS-1 receptor |
| UniProt accession | Q969F8 |
| Gene | KISS1R |
| Organism | Homo sapiens |
| Length | 398 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (474)
Diseases linked to this target (Open Targets).
- Kallmann syndrome · score 0.64
- Central precocious puberty · score 0.45
- hypogonadotropic hypogonadism · score 0.41
- neurodegenerative disease · score 0.37
- pituitary stalk interruption syndrome · score 0.28
- heel bone mineral density · score 0.27
- disease of genitourinary system · score 0.27
- ovarian cancer · score 0.26
- genetic disorder · score 0.19
- pancreatic adenocarcinoma · score 0.18
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q969F8-F1 | alphafold | PREDICTED | 75.26 | — |
Amino-acid sequence (398 residues)
MHTVATSGPN ASWGAPANAS GCPGCGANAS DGPVPSPRAV DAWLVPLFFA ALMLLGLVGN SLVIYVICRH KPMRTVTNFY IANLAATDVT FLLCCVPFTA LLYPLPGWVL GDFMCKFVNY IQQVSVQATC ATLTAMSVDR WYVTVFPLRA LHRRTPRLAL AVSLSIWVGS AAVSAPVLAL HRLSPGPRAY CSEAFPSRAL ERAFALYNLL ALYLLPLLAT CACYAAMLRH LGRVAVRPAP ADSALQGQVL AERAGAVRAK VSRLVAAVVL LFAACWGPIQ LFLVLQALGP AGSWHPRSYA AYALKTWAHC MSYSNSALNP LLYAFLGSHF RQAFRRVCPC APRRPRRPRR PGPSDPAAPH AELLRLGSHP APARAQKPGS SGLAARGLCV LGEDNAPL
Explore KiSS-1 receptor with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets